Uterine Fibroid Embolization
Procedure Description:
Common Questions Regarding this Procedure:
- What are Uterine Fibroids?
- What is Uterine Fibroid Embolization?
- Who is Eligible for Uterine Fibroid Embolization?
- What is the Pre-Procedure Evaluation?
- How is UFE Performed?
- What are the Results of Uterine Fibroid Embolization?
- What are the Risks of UFE?
- What is the Post-Procedural Care?
Uterine fibroids (leiomyomas) are benign tumors of the uterine muscle. These tumors form when the uterine muscle cells begin to grow as circular masses. In some women, large uterine fibroids can cause symptoms. These symptoms can include heavy menstrual bleeding, pelvic pain, pressure, pain during sexual intercourse, or a frequent and urgent need to void.
What is Uterine Fibroid Embolization?
Uterine fibroid embolization (UFE) represents a relatively new approach to treating fibroids. UFE is a minimally invasive procedure used to treat symptomatic fibroids by blocking the supply of blood to the fibroids. Using angiographic techniques similar to those used in heart catheterization, the interventional radiologist places a catheter into the uterine arteries. By injecting small particles into the arteries, the arteries feeding the fibroids are blocked. By cutting off the blood supply, the fibroids shrink and symptoms are resolved.
Who is Eligible for Uterine Fibroid Embolization?
Women with symptomatic fibroids are candidates for UFE. Any woman, regardless of the size and location of her fibroids, can undergo UFE. Some women have been able to achieve pregnancy after having UFE. UFE offers a minimally invasive option to surgery.
What is the Pre-Procedure Evaluation?
An interventional radiologist sees the patient for consultation at either the Spectrum Medical Group Office or at Eastern Maine Medical Center. During the evaluation, patients are fully informed about the risks and benefits of the procedure, as well as about expected results.
The procedure is done in the hospital with an overnight stay after the procedure. The patient is sedated using intravenous medications. In general the procedure takes 1 to 1 ½ hours. Initially a needle is used to enter the femoral artery. The catheter is advanced over the branch of the aorta and into the uterine artery on the opposite side of the puncture. A second arterial catheter is then placed from the opposite femoral artery to the other uterine artery. Using an angiogram, the uterine arteries are located. After the arteriogram, particles of poly vinyl alcohol are injected into the artery until blood flow to the fibroids stops. The catheter is then repositioned into the other uterine artery and the process is repeated. After the procedure, the patient is on bedrest for 6 hours to allow the puncture site to heal sufficiently.
What are the Results of Uterine Fibroid Embolization?
The expected average reduction in the volume of fibroids is 50% in three months, with reduction in the overall uterine volume of 35%. This reduction may be greater in some patients and less in others. Bleeding symptoms usually resolve immediately.
Complications are anticipated in less than 3% of patients. Serious possible complications include injury to the uterus from decreased blood supply or infection. Hysterectomy to treat either of these complications occurs in less than 1% of patients. The chance of other significant complications is less than 1%.
As the outcome of pregnancy following UFE is unknown, we do not recommend the procedure for women who plan to have children.
What is the Post-Procedural Care?
Each woman undergoing the procedure experiences varying degrees of pelvic pain and discomfort. The discomfort is most severe in the first 24 hours and women are given medication to control their discomfort. After an initial period of 6-8 hours bed rest, patients with mild to moderate symptoms may be discharged. Most patients are hospitalized overnight and are discharged home the next morning. Patients are discharged home with prescriptions for both narcotic pain medication to be used as needed and ibuprofen to help control uterine cramping.
© Copyright 2011 Spectrum Medical Group. All Rights Reserved.